About
Beijing Saifu Medical Research Institute Co., Ltd. relies on the Shanghai Institute of Materia Medica of the Chinese Academy of Sciences and the National Drug Safety Evaluation and Research Center of the State of Beijing to establish strategic partnerships with them to form a combination of technology, capital and enterprise operations. The core members of the company are researchers of the Institute of Materia Medica of the Chinese Academy of Sciences and researchers of the Academy of Military Medical Sciences. They have high scientific research and academic status in the fields of drug research and development and toxicology research, as well as rich drug development, GLP management and technical experience, and build and operate the platform. Provides strong talent and technical support.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 1,530 investors are based in Beijing, Beijing, China.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Stages
- series-a
- Sectors
- healthtech biotech
- Location
- Beijing, China
Contact Information
Find more investors like Safe
Search Investors